STOCK TITAN

Erasca Inc - ERAS STOCK NEWS

Welcome to our dedicated news page for Erasca (Ticker: ERAS), a resource for investors and traders seeking the latest updates and insights on Erasca.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Erasca's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Erasca's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.47%
Tags
clinical trial
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.3%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.3%
Tags
offering
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.34%
Tags
clinical trial
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.85%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.62%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
conferences
Erasca Inc

Nasdaq:ERAS

ERAS Rankings

ERAS Stock Data

311.24M
85.69M
23.33%
54.77%
5.97%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
San Diego

About ERAS

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.